Iranian Journal of Pediatrics

Published by: Kowsar

Clinical Significance of Late Onset Arthritis in Kawasaki Disease

Min Hwan Choi # 1 , Sung Hoon Kim # 1 , Ju Suk Lee 1 , Jinyoung Song 2 , I-Seok Kang 2 and June Huh 2 , *
Authors Information
1 Department of Pediatrics, Samsung Changwon Hospital, School of Medicine, Sungkyunkwan University , Changwon, South Korea
2 Department of Pediatrics, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea
# These authors are contributed equally as the first author.
Article information
  • Iranian Journal of Pediatrics: 29 (3); e84506
  • Published Online: May 7, 2019
  • Article Type: Research Article
  • Received: September 23, 2018
  • Revised: January 22, 2019
  • Accepted: January 29, 2019
  • DOI: 10.5812/ijp.84506

To Cite: Choi M H, Kim S H, Lee J S, Song J, Kang I, et al. Clinical Significance of Late Onset Arthritis in Kawasaki Disease, Iran J Pediatr. Online ahead of Print ; 29(3):e84506. doi: 10.5812/ijp.84506.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of kawasaki disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-99. doi: 10.1161/CIR.0000000000000484. [PubMed: 28356445].
  • 2. Rigante D, Valentini P, Onesimo R, Angelone DF, De Nisco A, Bersani G, et al. Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome. Rheumatol Int. 2010;30(4):535-9. doi: 10.1007/s00296-009-0960-1. [PubMed: 19455336].
  • 3. Gong GW, McCrindle BW, Ching JC, Yeung RS. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr. 2006;148(6):800-5. doi: 10.1016/j.jpeds.2006.01.039. [PubMed: 16769390].
  • 4. Izumi G, Narugami M, Saita Y, Matsuzawa T, Sugawara O, Kawamura N, et al. Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles. Pediatr Int. 2011;53(6):1087-9. doi: 10.1111/j.1442-200X.2011.03393.x. [PubMed: 22181570].
  • 5. Duzova A, Topaloglu R, Keskin M, Ozcelik U, Secmeer G, Tokgozoglu AM. An unusual pattern of arthritis in a child with Kawasaki syndrome. Clin Rheumatol. 2004;23(1):73-5. doi: 10.1007/s10067-003-0828-9. [PubMed: 14749991].
  • 6. Lee KY, Oh JH, Han JW, Lee JS, Lee BC. Arthritis in Kawasaki disease after responding to intravenous immunoglobulin treatment. Eur J Pediatr. 2005;164(7):451-2. doi: 10.1007/s00431-005-1653-8. [PubMed: 15782294].
  • 7. Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, et al. N-terminal pro-brain natriuretic Peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J. 2013;77(8):2097-101. [PubMed: 23615024].
  • 8. Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, et al. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease. Eur J Pediatr. 2016;175(12):1997-2003. doi: 10.1007/s00431-016-2798-3. [PubMed: 27798729].
  • 9. Baek JY, Song MS. Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. Korean J Pediatr. 2016;59(2):80-90. doi: 10.3345/kjp.2016.59.2.80. [PubMed: 26958067]. [PubMed Central: PMC4781736].
  • 10. Sato S, Uejima Y, Suganuma E, Takano T, Kawano Y. A retrospective study: Acute rheumatic fever and post-streptococcal reactive arthritis in Japan. Allergol Int. 2017;66(4):617-20. doi: 10.1016/j.alit.2017.04.001. [PubMed: 28442182].
  • 11. Essenmacher AC, Khurram N, Bismack GT. A case of reactive arthritis due to Clostridium difficile colitis. J Community Hosp Intern Med Perspect. 2016;6(1):30151. doi: 10.3402/jchimp.v6.30151. [PubMed: 26908381]. [PubMed Central: PMC4763550].
  • 12. Alvarez EP, Rey F, Pena SC, Rubio A, Calvo C, Collado P. Has joint involvement lessened in Kawasaki disease? Reumatol Clin. 2017;13(3):145-9. doi: 10.1016/j.reuma.2016.04.004. [PubMed: 27263965].
  • 13. Rowley AH, Shulman ST. The epidemiology and pathogenesis of Kawasaki disease. Front Pediatr. 2018;6:374. doi: 10.3389/fped.2018.00374. [PubMed: 30619784]. [PubMed Central: PMC6298241].
  • 14. Chen KYH, Messina N, Germano S, Bonnici R, Freyne B, Cheung M, et al. Innate immune responses following Kawasaki disease and toxic shock syndrome. PLoS One. 2018;13(2). e0191830. doi: 10.1371/journal.pone.0191830. [PubMed: 29447181]. [PubMed Central: PMC5813928].
  • 15. Cameron SA, White SM, Arrollo D, Shulman ST, Rowley AH. Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis. Clin Exp Immunol. 2017;190(2):244-50. doi: 10.1111/cei.13010. [PubMed: 28707750]. [PubMed Central: PMC5629428].
  • 16. Sarma PK, Misra R, Aggarwal A. Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis. Clin Rheumatol. 2008;27(3):289-94. doi: 10.1007/s10067-007-0701-3. [PubMed: 17703334].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments